Ruti Aga Handed Six-Year Ban: A Family Member's Forged Prescription Turned a Two-Year Case Into Career Death

The Athletics Integrity Unit (AIU) has imposed a six-year ban on Ethiopian marathon runner Ruti Aga. The 32-year-old has been sanctioned on two counts: the presence of a prohibited substance, and the submission of a forged medical prescription. According to the AIU statement issued on Thursday, the ban is effective from 10 September — the same date from which she had already been provisionally suspended. The case began at a half marathon in China in March, which Aga won. A sample collected there returned an adverse finding for methylprednisolone. Several reports described it as a 'prohibited steroid', but that classification is technically incorrect — and the error changes the entire legal reading of the case. What the substance is, and why the distinction matters Methylprednisolone is a glucocorticoid, not an anabolic steroid. It sits in class S9 of the WADA Prohibited List. Under the current List, S9 glucocorticoids are prohibited in-competition only, and only when administered by injection, orally or rectally. A therapeutic knee injection given out-of-competition is entirely legal. That means the case never hinged on 'steroid use'. It hinged on two things: the route of administration and the timing relative to the competition. In road racing, the in-competition testing window opens at 23:59 the day before the race, so an injection given days earlier can still be caught. Aga had a legitimate defence available — provided she had real medical records to back it. The arithmetic of six years The structure of the AIU decision is standard: two years for the presence violation and four years for tampering — six years in total. A two-year sanction is typical of a Specified Substance finding where intent is not proven. The separate four-year component makes clear the panel treated the forged document as fully culpable, with no mitigation. The significant point is this: had Aga produced genuine records and properly explained the timing and route of the injection, a no-fault or no-significant-fault argument would have remained open — potentially a reprimand or a substantially reduced period. The tampering charge would never have arisen. In other words, the one defence that could have worked was destroyed by the forged prescription. A properly managed athlete would either have held or applied for a TUE, or observed the route-specific washout period. Neither happened. Three separate verification failures According to the AIU investigation, Aga submitted a prescription written for the treatment of a knee injury. Three things emerged. First, the clinic named on the prescription did not exist. Second, the person who wrote it was a family member with no medical registration. Third, that person claimed to have used 'an old prescription pad from a former workplace' — and the clinic named on the pad explicitly disowned the claim. Three independent verification checks, all three failed. This is not a clerical slip. It is a picture of a medical support structure in which the athlete has no credentialed team physician at all. It also matters that the tampering sanction arises not from a document alone but from statements made during the investigation — what was said in interview became part of the case. The career calculus Aga is 32. The six-year ban runs from 10 September, which puts her return age at roughly 38. The depth of Ethiopian women's marathoning is such that even a 2:18–2:20 performer cannot count on national selection. A 38-year-old with a doping record is, in practical terms, unselectable. At elite level this sanction is functionally a lifetime ban, and the 2028 Olympic cycle is gone entirely. Her record reads differently. She won the 2026 Tokyo Marathon and finished second at World Marathon Majors three times. Her personal best of 2:18:34 came in Berlin in 2026, where she finished second. Those results predate the date this case is anchored to and are therefore not automatically annulled — the AIU statement does not set out the scope of disqualification. Standard practice, however, would void the result and prize money from the competition at which the sample was collected. What the case actually tells us Performance is secondary in this story. No time, no splits and no field description are available for the March half marathon — only that Aga won it. Any judgement of form based on that race would be inference beyond the facts. The one performance-relevant fact is that the race was of elite standard and carried in-competition testing. The real question is medical governance. Chronic knee pathology is common in distance running, and racing through pain creates a strong incentive to protect appearance-fee income. Glucocorticoids are the cheapest and most available tool for that. When there is no formal medical structure around an athlete, a forged prescription becomes the attempt to fill that gap. Responsibility rests entirely with the athlete, but the roots sit partly in the system. Tampering charges are clustering in AIU road-running cases, which suggests the enforcement frontier is shifting from detection to document verification. China's label-race circuit — where large appearance-fee budgets, deep East African elite fields and AIU testing coincide — will only come under heavier scrutiny. The Ethiopian federation has issued no statement on the case; the AIU remains the only cited source. Appeal and what comes next Formally, Aga can appeal to CAS — typically within about 21 days of the reasoned decision. But the forgery finding rests on documentary evidence and would be very hard to overturn. Backdating the ban to 10 September is not a concession: time served under provisional suspension counts against the sanction, so the athlete gains nothing in real terms. What makes the case unusual is the headline number: six years for a substance with no proven endurance benefit. That figure will be cited from both directions — as evidence of AIU rigour, and as evidence of disproportionate enforcement against African road runners.